UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Atrial‐like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial‐selective pharmacology

EMBO molecular medicine, 2015-04, Vol.7 (4), p.394-410

2015

Volltextzugriff (PDF)

Analysis of drug-induced and spontaneous cardioversions reveals similar patterns leading to termination of atrial fibrillation

Frontiers in physiology, 2024-07, Vol.15, p.1399037

2024

Volltextzugriff (PDF)

New Drugs Targeting the Cardiac Ultra-Rapid Delayed-Rectifier Current (IKur): Rationale, Pharmacology and Evidence for Potential Therapeutic Value

Journal of cardiovascular pharmacology, 2008-08, Vol.52 (2), p.105-120

2008

Volltextzugriff (PDF)

Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S6 mutations at F656 or Y652

British journal of pharmacology, 2003-07, Vol.139 (5), p.887-898

2003

Volltextzugriff (PDF)

Inhibition of voltage-gated Na+ currents by eleclazine in rat atrial and ventricular myocytes

Heart rhythm O2, 2020-08, Vol.1 (3), p.206-214

2020

Volltextzugriff (PDF)

High affinity HERG K + channel blockade by the antiarrhythmic agent dronedarone: resistance to mutations of the S6 residues Y652 and F656

Biochemical and biophysical research communications, 2004-12, Vol.325 (3), p.883-891

2004

Volltextzugriff (PDF)

hERG K + channel blockade by the antipsychotic drug thioridazine: An obligatory role for the S6 helix residue F656

Biochemical and biophysical research communications, 2006-12, Vol.351 (1), p.273-280

2006

Volltextzugriff (PDF)

Novel K+ Channel Targets in Atrial Fibrillation Drug Development—Where Are We?

Journal of cardiovascular pharmacology, 2015-11, Vol.66 (5), p.412-431

2015

Volltextzugriff (PDF)

New pharmacological approaches to atrial fibrillation

Drug discovery today, 2012-07, Vol.17 (13-14), p.654-659

2012

Volltextzugriff (PDF)

Investigating dynamic protocol-dependence of hERG potassium channel inhibition at 37 degrees C: Cisapride versus dofetilide

Journal of pharmacological and toxicological methods, 2010-03, Vol.61 (2), p.178-191

2010

Volltextzugriff (PDF)

Potent inhibition of human cardiac potassium (HERG) channels by the anti-estrogen agent clomiphene—without QT interval prolongation

Biochemical and biophysical research communications, 2004-05, Vol.318 (2), p.556-561

2004

Volltextzugriff (PDF)

The N588K-HERG K + channel mutation in the ‘short QT syndrome’: Mechanism of gain-in-function determined at 37 °C

Biochemical and biophysical research communications, 2005-08, Vol.334 (2), p.441-449

2005

Volltextzugriff (PDF)

Investigating dynamic protocol-dependence of hERG potassium channel inhibition at 37 °C: Cisapride versus dofetilide

Journal of pharmacological and toxicological methods, 2010-03, Vol.61 (2), p.178-191

2010

Volltextzugriff (PDF)

The low-potency, voltage-dependent HERG blocker propafenone--molecular determinants and drug trapping

Molecular pharmacology, 2004-11, Vol.66 (5), p.1201-1212

2004

Volltextzugriff (PDF)

Activation of Glibenclamide-Sensitive ATP-Sensitive K+ Channels During β-Adrenergically Induced Metabolic Stress Produces a Substrate for Atrial Tachyarrhythmia

Circulation. Arrhythmia and electrophysiology, 2012-12, Vol.5 (6), p.1184-1192

2012

Volltextzugriff (PDF)

Inhibition of the HERG K + channel by the antifungal drug ketoconazole depends on channel gating and involves the S6 residue F656

FEBS letters, 2006-04, Vol.580 (8), p.1999-2005

2006

Volltextzugriff (PDF)

Clemastine, a conventional antihistamine, is a high potency inhibitor of the HERG K + channel

Journal of molecular and cellular cardiology, 2006, Vol.40 (1), p.107-118

2006

Volltextzugriff (PDF)

Preferential closed channel blockade of HERG potassium currents by chemically synthesised BeKm-1 scorpion toxin

FEBS letters, 2003-07, Vol.547 (1), p.20-26

2003

Volltextzugriff (PDF)

Troubleshooting problems with in vitro screening of drugs for QT interval prolongation using HERG K + channels expressed in mammalian cell lines and Xenopus oocytes

Journal of pharmacological and toxicological methods, 2002-09, Vol.48 (2), p.65-80

2002

Volltextzugriff (PDF)

Lidoflazine is a high affinity blocker of the HERG K +channel

Journal of molecular and cellular cardiology, 2004-05, Vol.36 (5), p.701-705

2004

Volltextzugriff (PDF)

Characterisation of recombinant HERG K + channel blockade by the Class Ia antiarrhythmic drug procainamide

Biochemical and biophysical research communications, 2003-06, Vol.306 (2), p.388-393

2003

Volltextzugriff (PDF)

Eleclazine Inhibition of Voltage-gated Sodium Currents in Rat Atrial and Ventricular Myocytes

Biophysical journal, 2020-02, Vol.118 (3), p.104a-104a

2020

Volltextzugriff (PDF)

The neuroprotective agent sipatrigine blocks multiple cardiac ion channels and causes triangulation of the ventricular action potential

Clinical and experimental pharmacology & physiology, 2005-12, Vol.32 (12), p.1088-1096

2005

Volltextzugriff (PDF)

Molecular Mechanism of the Potent Benzopyran-G1 Blocker of Heteromeric G-Protein Gated Potassium Channels

Biophysical journal, 2021-02, Vol.120 (3), p.203a-203a

2021

Volltextzugriff (PDF)

The N588K-HERG K+ channel mutation in the 'short QT syndrome': mechanism of gain-in-function determined at 37 degrees C

Biochemical and biophysical research communications, 2005-08, Vol.334 (2), p.441

2005

Volltextzugriff (PDF)

1 – 25 von 241

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(150)
Mit Volltextzugriff
(216)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(241)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(124)
Life Sciences & Biomedicine
(94)
Humans
(58)
Female
(32)
History
(26)
Arts & Humanities
(25)
General & Internal Medicine
(22)
Male
(22)
Medicine, General & Internal
(21)
Physical Sciences
(21)
Medical Research
(20)
Technology
(19)
Animals
(18)
Medical Study & Revision Guides & Reference Material
(16)
Medicine: General Issues
(16)
Middle Aged
(16)
Physics
(16)
Instruments & Instrumentation
(15)
Adult
(13)
Cardiac & Cardiovascular Systems
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Atrial‐like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial‐selective pharmacology

Analysis of drug-induced and spontaneous cardioversions reveals similar patterns leading to termination of atrial fibrillation

New Drugs Targeting the Cardiac Ultra-Rapid Delayed-Rectifier Current (IKur): Rationale, Pharmacology and Evidence for Potential Therapeutic Value

Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S6 mutations at F656 or Y652

Inhibition of voltage-gated Na+ currents by eleclazine in rat atrial and ventricular myocytes

High affinity HERG K + channel blockade by the antiarrhythmic agent dronedarone: resistance to mutations of the S6 residues Y652 and F656

hERG K + channel blockade by the antipsychotic drug thioridazine: An obligatory role for the S6 helix residue F656

Novel K+ Channel Targets in Atrial Fibrillation Drug Development—Where Are We?

New pharmacological approaches to atrial fibrillation

Investigating dynamic protocol-dependence of hERG potassium channel inhibition at 37 degrees C: Cisapride versus dofetilide

Potent inhibition of human cardiac potassium (HERG) channels by the anti-estrogen agent clomiphene—without QT interval prolongation

The N588K-HERG K + channel mutation in the ‘short QT syndrome’: Mechanism of gain-in-function determined at 37 °C

Investigating dynamic protocol-dependence of hERG potassium channel inhibition at 37 °C: Cisapride versus dofetilide

The low-potency, voltage-dependent HERG blocker propafenone--molecular determinants and drug trapping

Activation of Glibenclamide-Sensitive ATP-Sensitive K+ Channels During β-Adrenergically Induced Metabolic Stress Produces a Substrate for Atrial Tachyarrhythmia

Inhibition of the HERG K + channel by the antifungal drug ketoconazole depends on channel gating and involves the S6 residue F656

Clemastine, a conventional antihistamine, is a high potency inhibitor of the HERG K + channel

Preferential closed channel blockade of HERG potassium currents by chemically synthesised BeKm-1 scorpion toxin

Troubleshooting problems with in vitro screening of drugs for QT interval prolongation using HERG K + channels expressed in mammalian cell lines and Xenopus oocytes

Lidoflazine is a high affinity blocker of the HERG K +channel

Characterisation of recombinant HERG K + channel blockade by the Class Ia antiarrhythmic drug procainamide

Eleclazine Inhibition of Voltage-gated Sodium Currents in Rat Atrial and Ventricular Myocytes

The neuroprotective agent sipatrigine blocks multiple cardiac ion channels and causes triangulation of the ventricular action potential

Molecular Mechanism of the Potent Benzopyran-G1 Blocker of Heteromeric G-Protein Gated Potassium Channels

The N588K-HERG K+ channel mutation in the 'short QT syndrome': mechanism of gain-in-function determined at 37 degrees C

Suchergebnisse filtern